{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T10:53:35Z","timestamp":1775818415064,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000204","name":"U.S. Department of Housing and Urban Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000204","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I50 CU000179-01"],"award-info":[{"award-number":["I50 CU000179-01"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["ILHHU0049-19"],"award-info":[{"award-number":["ILHHU0049-19"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.jad.2022.08.042","type":"journal-article","created":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T11:08:22Z","timestamp":1661166502000},"page":"1-2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Does hypoxemia contribute to treatment-resistant depression in patients with COPD by decreasing serotonin synthesis in the brain?"],"prefix":"10.1016","volume":"317","author":[{"given":"Nicholas","family":"Barreras","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Feld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Israel","family":"Rubinstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2022.08.042_bb0005","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1378\/chest.08-0965","article-title":"The risk for depression comorbidity in patients with COPD","volume":"135","author":"van den Bemt","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.jad.2022.08.042_bb0010","doi-asserted-by":"crossref","first-page":"18911","DOI":"10.1038\/s41598-021-98245-9","article-title":"Normobaric oxygen treatment for mild-to-moderate depression: a randomized, double-blind, proof-of-concept trial","volume":"11","author":"Bloch","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jad.2022.08.042_bb0015","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1126\/science.182.4107.72","article-title":"Brain tryptophan hydroxylation: dependence on arterial oxygen tension","volume":"182","author":"Davis","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.jad.2022.08.042_bb0020","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/ppc.12169","article-title":"Major depression in long-term oxygen therapy dependent chronic obstructive pulmonary disease","volume":"54","author":"Kayhan","year":"2018","journal-title":"Perspect. Psychiatr. Care"},{"key":"10.1016\/j.jad.2022.08.042_bb0025","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.neuint.2005.07.006","article-title":"Increasing blood oxygen increases an index of 5-HT synthesis in human brain as measured using \u03b1-[(11)C]methyl-L-tryptophan and positron emission tomography","volume":"47","author":"Nishikawa","year":"2005","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.jad.2022.08.042_bb0030","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neubiorev.2018.05.018","article-title":"TPH2 polymorphisms across the spectrum of psychiatric morbidity: a systematic review and meta-analysis","volume":"92","author":"Ottenhof","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jad.2022.08.042_bb0035","article-title":"Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease","volume":"12","author":"Pollok","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jad.2022.08.042_bb0040","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3390\/ph13060116","article-title":"Pharmacological treatments for patients with treatment-resistant depression","volume":"13","author":"Ruberto","year":"2020","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.jad.2022.08.042_bb0045","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1378\/chest.09-0614","article-title":"COPD and the risk of depression","volume":"137","author":"Schneider","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.jad.2022.08.042_bb0050","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.2147\/COPD.S313841","article-title":"The relationship between anxiety, depression and treatment adherence in chronic obstructive pulmonary disease: a systematic review","volume":"16","author":"Volpato","year":"2021","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032722008989?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032722008989?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T03:19:54Z","timestamp":1759029594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032722008989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":10,"alternative-id":["S0165032722008989"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2022.08.042","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does hypoxemia contribute to treatment-resistant depression in patients with COPD by decreasing serotonin synthesis in the brain?","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2022.08.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}